High Resolution Diffusion Weighted Imaging in Prostate
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age55+
SponsorThe First Affiliated Hospital with Nanjing Medical University
About this trial
hrDWI might be an alternative to cDWI for the prostate imaging.
1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps;
Complete clinical information.
Disqualifiers
None
Trial population
Men larger than 55 years old were eligible to participate if they had a clinical suspicion of PCa with no previous biopsy. This included those with elevated PSA (\> 4 ng/ml), or with suspicious digital rectal examination findings, or with suspicious findings on ultrasound examination, or with a family history of PCa.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
image quality evaluation
objective and subjective image quality and lesion conspicuity
Time frame
2024.01-2025.12Secondary outcomes
1
prostate cancer diagnosis
the diagnostic accuracy of prostate cancer
Time frame
2024.01-2025.12Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov